Barclays
TMDX icon

Barclays’s Transmedics TMDX Stock Holding History

Barclays’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,000
Closed -$1.77M – 5295
2024
Q1 		$1.77M Buy
+24,000
New +$1.98M ﹤0.01% 2675

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Barclays's TMDX Position: Q2 2026 in Review

Barclays increased its Transmedics (TMDX) stake by 25% in Q2 2026, buying an estimated $3.98M and bringing the position to 237,615 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Barclays first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $30M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Barclays held 237,615 shares of Transmedics worth $15.8M as of Q2 2026.
  • Barclays bought 47,037 Transmedics shares in Q2 2026, an estimated $3.98M.
  • Transmedics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1253 holding.
  • Barclays first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Barclays's Transmedics position peaked at $30M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.